Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL).
Harland M, Goldstein AM, Kukalizch K, Taylor C, Hogg D, Puig S, Badenas C, Gruis N, ter Huurne J, Bergman W, Hayward NK, Stark M, Tsao H, Tucker MA, Landi MT, Scarra GB, Ghiorzo P, Kanetsky PA, Elder D, Mann GJ, Holland EA, Bishop DT, Bishop JN; GenoMEL, the Melanoma Genetics Consortium. Harland M, et al. Among authors: stark m. Eur J Cancer. 2008 Jun;44(9):1269-74. doi: 10.1016/j.ejca.2008.03.005. Epub 2008 Apr 3. Eur J Cancer. 2008. PMID: 18394881 Free PMC article.
Lack of genetic and epigenetic changes in CDKN2A in melanocytic nevi.
Welch J, Millar D, Goldman A, Heenan P, Stark M, Eldon M, Clark S, Martin NG, Hayward NK. Welch J, et al. Among authors: stark m. J Invest Dermatol. 2001 Aug;117(2):383-4. doi: 10.1046/j.0022-202x.2001.01391.x. J Invest Dermatol. 2001. PMID: 11511321 Free article. No abstract available.
High frequency of BRAF mutations in nevi.
Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, Moses TY, Hostetter G, Wagner U, Kakareka J, Salem G, Pohida T, Heenan P, Duray P, Kallioniemi O, Hayward NK, Trent JM, Meltzer PS. Pollock PM, et al. Among authors: stark m. Nat Genet. 2003 Jan;33(1):19-20. doi: 10.1038/ng1054. Epub 2002 Nov 25. Nat Genet. 2003. PMID: 12447372
Localization of a novel melanoma susceptibility locus to 1p22.
Gillanders E, Juo SH, Holland EA, Jones M, Nancarrow D, Freas-Lutz D, Sood R, Park N, Faruque M, Markey C, Kefford RF, Palmer J, Bergman W, Bishop DT, Tucker MA, Bressac-de Paillerets B, Hansson J, Stark M, Gruis N, Bishop JN, Goldstein AM, Bailey-Wilson JE, Mann GJ, Hayward N, Trent J; Lund Melanoma Study Group; Melanoma Genetics Consortium. Gillanders E, et al. Among authors: stark m. Am J Hum Genet. 2003 Aug;73(2):301-13. doi: 10.1086/377140. Epub 2003 Jul 3. Am J Hum Genet. 2003. PMID: 12844286 Free PMC article.
Microarray expression profiling in melanoma reveals a BRAF mutation signature.
Pavey S, Johansson P, Packer L, Taylor J, Stark M, Pollock PM, Walker GJ, Boyle GM, Harper U, Cozzi SJ, Hansen K, Yudt L, Schmidt C, Hersey P, Ellem KA, O'Rourke MG, Parsons PG, Meltzer P, Ringnér M, Hayward NK. Pavey S, et al. Among authors: stark m. Oncogene. 2004 May 20;23(23):4060-7. doi: 10.1038/sj.onc.1207563. Oncogene. 2004. PMID: 15048078
BRAF polymorphisms and risk of melanocytic neoplasia.
James MR, Roth RB, Shi MM, Kammerer S, Nelson MR, Stark MS, Dumenil T, Montgomery GW, Hayward NK, Martin NG, Braun A, Duffy DL. James MR, et al. Among authors: stark ms. J Invest Dermatol. 2005 Dec;125(6):1252-8. doi: 10.1111/j.0022-202X.2005.23937.x. J Invest Dermatol. 2005. PMID: 16354196 Free article.
1,176 results